EBITDA margin společnosti NeuroVive Pharmaceutical AB
Jaká je hodnota metriky EBITDA margin společnosti NeuroVive Pharmaceutical AB?
Hodnota metriky EBITDA margin společnosti NeuroVive Pharmaceutical AB je -79,544.30%
Jaká je definice metriky EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin společností v sektoru Health Care sektor na OTC ve srovnání se společností NeuroVive Pharmaceutical AB
Čemu se věnuje společnost NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Firmy s metrikou ebitda margin podobnou společnosti NeuroVive Pharmaceutical AB
- Hodnota metriky EBITDA margin společnosti Eagle Mountain Mining je -80,928.28%
- Hodnota metriky EBITDA margin společnosti RosCan Gold je -80,206.96%
- Hodnota metriky EBITDA margin společnosti Cannonau je -80,183.27%
- Hodnota metriky EBITDA margin společnosti Revolution Medicines Inc je -80,180.19%
- Hodnota metriky EBITDA margin společnosti NeuroVive Pharmaceutical AB je -79,734.59%
- Hodnota metriky EBITDA margin společnosti Carbios SA je -79,708.33%
- Hodnota metriky EBITDA margin společnosti NeuroVive Pharmaceutical AB je -79,544.30%
- Hodnota metriky EBITDA margin společnosti CropLogic je -79,147.31%
- Hodnota metriky EBITDA margin společnosti Seneca Biopharma Inc je -78,278.65%
- Hodnota metriky EBITDA margin společnosti Karuna Therapeutics Inc je -75,393.88%
- Hodnota metriky EBITDA margin společnosti Accelerate Resources je -75,249.13%
- Hodnota metriky EBITDA margin společnosti Pacific American je -72,236.00%
- Hodnota metriky EBITDA margin společnosti Mako Gold je -72,194.15%